This inventor holds 1 USPTO granted patent. Top assignee: N. V. Sopar S.a.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Santiago Castanys: Innovator in Therapeutic Agents
Introduction
Santiago Castanys is a notable inventor based in Granada, Spain. He has made significant contributions to the field of therapeutic agents, particularly in the fight against Leishmaniasis. His innovative approach involves the use of submicroscopic particles, showcasing his commitment to advancing medical science.
Latest Patents
Santiago Castanys holds a patent for therapeutic agents in the form of submicroscopic particles. This invention relates to new therapeutic agents designed to combat Leishmaniasis. The therapeutic agents consist of particles with a diameter of less than 500 nanometers, obtained through the micellar polymerization of an alkyl cyanoacrylate. The alkyl chain in these particles contains between 1 to 12 carbon atoms. Notably, these agents can be administered parenterally, offering a promising avenue for treatment.
Career Highlights
Throughout his career, Santiago has demonstrated a strong dedication to research and innovation. His work has led to the development of effective therapeutic solutions, contributing to the medical community's understanding of Leishmaniasis. His patent reflects his expertise and commitment to improving health outcomes.
Collaborations
Santiago Castanys collaborates with Antonio Osuna Carillo De Albornoz, further enhancing his research efforts. Their partnership exemplifies the importance of teamwork in the field of innovation and invention.
Conclusion
Santiago Castanys is a pioneering inventor whose work in therapeutic agents has the potential to make a significant impact on the treatment of Leishmaniasis. His innovative approach and dedication to research highlight the importance of continued advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile